Bookmark

Add to MyYahoo RSS

Scios News

News on Scios (Ticker: JNJ) continually updated from thousands of sources around the net.

Friday Jul 25 | CNN

Xarelto Side Effects Lawsuit News: New Lawsuit Alleges Xarelto...

Close to 10 Xarelto side effects lawsuits have been filed in the United States against Janssen Pharmaceuticals, a division of Johnson & Johnson and Germany-based Bayer AG over its blood-thinning medication.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Mon Jul 21, 2014

Forbes.com

Daily Dividend Report: JNJ, HAL, AGN, APD, SPN, ZION, BRO

Johnson & Johnson has declared a cash dividend for the third quarter of 2014 of $0.70 per share on the company's common stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Sun Jul 20, 2014

The Jersey Journal

Work in progress: Johnson & Johnson 'outsider' helps revive recall-plagued consumer unit

To fix Johnson & Johnson's disgraced consumer unit, Sandra Peterson took a gamble, jettisoning several well-known brands, including K-Y Jelly, to concentrate on big sellers such as the pain pill Tylenol.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Micrus, OrthoClinical Diagnostics, Medical Equipment

Fri Jul 18, 2014

Examiner.com

Johnson & Johnson inspires caring in children with 'Once Upon A Care'

A good value system is essential when raising a child. You want your child to grow up to be kind, caring and compassionate to everyone who enters their life whether a family member or a stranger.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Tue Jul 15, 2014

Value Line

Dow-30 Earnings: Johnson & Johnson

Value Line is regarded as the best independent research available. More than just recommendations, Value Line provides the rationale behind its picks for greater understanding.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Seattle Times

Stock futures edge up following mixed retail data

Stock futures edged higher Tuesday as investors digested mixed U.S. retail sales data and several corporate earnings reports.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

The Arizona Republic

Johnson & Johnson 2Q profit climbs 13 percent

Johnson & Johnson 2Q profit climbs 13 percent J&J 2Q profit climbs 13 percent Check out this story on azcentral.com: http://azc.cc/1mGC1SW Johnson & Johnson on Tuesday reported earnings that climbed by 13 percent in its second quarter, and topped analysts' expectations.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

The Jersey Journal

Johnson & Johnson posts strong 2nd quarter earnings on new medicine sales

Johnson & Johnson, the world's biggest maker of health-care products, raised its 2014 earnings forecast for the second time this year after second-quarter profit soared on demand for the company's newest medicines.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, OrthoClinical Diagnostics, Medical Equipment

Sun Jul 13, 2014

TheStreet.com

Johnson & Johnson Prescribes Healthy Returns Without M&A or Breakup

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Wed Jul 09, 2014

Reuters

UPDATE 2-Sodexo cuts sales growth forecast due to contract delays

Sodexo, the world's second-biggest catering services company, cut it full-year sales growth forecast on Wednesday, warning its fourth quarter would be weaker than expected due to the delayed start-up of some large contracts.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••